WO2008040995A8 - Indazoles for use as dpp-iv inhibitors - Google Patents
Indazoles for use as dpp-iv inhibitorsInfo
- Publication number
- WO2008040995A8 WO2008040995A8 PCT/GB2007/003788 GB2007003788W WO2008040995A8 WO 2008040995 A8 WO2008040995 A8 WO 2008040995A8 GB 2007003788 W GB2007003788 W GB 2007003788W WO 2008040995 A8 WO2008040995 A8 WO 2008040995A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dpp
- inhibitors
- indazoles
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
The present invention relates to indazole derivatives useful as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0619906.1 | 2006-10-07 | ||
GB0619906A GB0619906D0 (en) | 2006-10-07 | 2006-10-07 | Compounds |
GB0624719A GB0624719D0 (en) | 2006-12-12 | 2006-12-12 | Compounds |
GB0624719.1 | 2006-12-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2008040995A1 WO2008040995A1 (en) | 2008-04-10 |
WO2008040995A8 true WO2008040995A8 (en) | 2008-10-23 |
WO2008040995A9 WO2008040995A9 (en) | 2008-12-31 |
Family
ID=38894055
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/003788 WO2008040995A1 (en) | 2006-10-07 | 2007-10-04 | Indazoles for use as dpp-iv inhibitors |
PCT/GB2007/003758 WO2008040974A1 (en) | 2006-10-07 | 2007-10-04 | Indoles for use as dpp-iv inhibitors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/003758 WO2008040974A1 (en) | 2006-10-07 | 2007-10-04 | Indoles for use as dpp-iv inhibitors |
Country Status (1)
Country | Link |
---|---|
WO (2) | WO2008040995A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
WO2011107494A1 (en) | 2010-03-03 | 2011-09-09 | Sanofi | Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
US8765668B2 (en) * | 2010-06-04 | 2014-07-01 | Lek Pharmaceuticals D.D. | Methods of synthesis of β-aminobutyryl substituted compounds |
EP2392575A1 (en) | 2010-06-04 | 2011-12-07 | LEK Pharmaceuticals d.d. | A novel synthetic approach to ß-aminobutyryl substituted compounds |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN102627648B (en) * | 2012-04-14 | 2014-11-12 | 江苏施美康药业股份有限公司 | Preparation method of sitagliptin |
EP2911655A1 (en) | 2012-10-24 | 2015-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tpl2 kinase inhibitors for preventing or treating diabetes and for promoting -cell survival |
US10426818B2 (en) | 2015-03-24 | 2019-10-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Method and pharmaceutical composition for use in the treatment of diabetes |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
CN104987338B (en) * | 2015-07-30 | 2017-07-21 | 新发药业有限公司 | A kind of preparation method of Sitagliptin phosphate key intermediate |
CN106668056B (en) * | 2016-11-08 | 2019-12-10 | 中国人民解放军第二军医大学 | Combination of adenosine and nNOS inhibitors for preventing central nervous system oxygen poisoning |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005265148B2 (en) * | 2004-06-21 | 2011-01-20 | Merck Sharp & Dohme Corp. | Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
-
2007
- 2007-10-04 WO PCT/GB2007/003788 patent/WO2008040995A1/en active Application Filing
- 2007-10-04 WO PCT/GB2007/003758 patent/WO2008040974A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008040974A1 (en) | 2008-04-10 |
WO2008040995A9 (en) | 2008-12-31 |
WO2008040995A1 (en) | 2008-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008040995A8 (en) | Indazoles for use as dpp-iv inhibitors | |
HUS2000049I1 (en) | Substituted indazole derivatives active as kinase inhibitors | |
GB2465132B (en) | Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors | |
HUS1400008I1 (en) | Administration of dipeptidyl peptidase inhibitors | |
EP2133077A4 (en) | Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv | |
AP2320A (en) | Proline derivatives and their use as dipeptidyl peptidase IV inhibitors. | |
MX2008001799A (en) | Pharmaceutical composition comprising a dpp-iv inhibitor. | |
IL177629A0 (en) | Dipeptidyl peptidase inhibitors | |
HK1119086A1 (en) | Dipeptidyl peptidase inhibitors for treating diabetes | |
IL186607A0 (en) | Dipeptidyl peptidase-iv inhibitors | |
EP2057158B8 (en) | Triazole derivatives as kinase inhibitors | |
IL189544A0 (en) | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) | |
PL2247602T3 (en) | Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes | |
WO2007143434A3 (en) | Indazole and isoindole derivatives as glucokinase activating agents | |
EP1978804A4 (en) | Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
WO2009111239A3 (en) | Pyrrolidine derivatives | |
EP2521721A4 (en) | 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors | |
WO2010107809A3 (en) | Methods for preparing dpp-iv inhibitor compounds | |
ZA201102597B (en) | Novel dipeptidyl peptidase (dp-iv) compounds | |
ZA200802855B (en) | Dipeptidyl peptidase inhibitors for treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07824042 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07824042 Country of ref document: EP Kind code of ref document: A1 |